Formoterol in the management of chronic obstructive pulmonary disease.

The current pharmacological therapy for COPD is limited in its ability to modify the progressive decline in lung function, a hallmark of COPD, and to reduce its mortality, which is associated with progressive disease, as was recently reported by the trial Towards a Revolution in COPD Health (TORCH) where the reduction in mortality failed to reach statistical significance ( Calverley et al 2007 ).

also in 6,035 other papers